KUBIX logo — Pioneering precision in biotech with comprehensive reagent k...

KUBIX

Pioneering precision in biotech with comprehensive reagent kits and advanced genetic analysis services

Founded 2004 Corporate Round Total: $50.00M Biotechnology, Health Care

General Information

Company Name KUBIX
Founded Year 2004
Industries Biotechnology, Health Care
Funding Stage Corporate Round
Social

BounceWatch is an independent company data service, not affiliated with KUBIX. To contact KUBIX, visit kubix.co.jp.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does KUBIX compare?

A PDF of KUBIX and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting KUBIX soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About KUBIX

KUBIX is a biotech startup founded in 2004 that focuses on pioneering precision in biotech with comprehensive reagent kits and advanced genetic analysis services. The company's offerings include contract inspection services, next-generation sequencing analysis, gene expression analysis via microarray, genetic analysis with real-time PCR, and nucleic acid extraction and preparation services. The last investment in KUBIX was a Corporate Round investment on 18 January 2021 led by Toho Holdings. The startup operates in the Biotechnology and Health Care industries, positioning itself as a key player in the advancement of biotech solutions.

Business keywords: biotech, precision, reagent kits, genetic analysis, next-generation sequencing, contract inspection, microarray, real-time PCR, nucleic acid extraction, sales, development, services

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Corporate Round Undisclosed 1
Toho Holdings
18 Jan 2021
Venture Round Undisclosed 1
Shinkin Capital
26 Nov 2015
Venture Round ¥50.00M 1
Japan Venture Capital Association
07 Apr 2013

KUBIX Alternatives & Competitors

View All Alternatives
KUBIX vs

Your partner for real-time PCR applications, gene expression analysis and pathogen detection assays

14 employees
Analytics, Biopharma
KUBIX vs

Leader in the development, production and sales of pharmacogenetics tests for cancer precision medic...

Private Equity
76 employees
Biotechnology, Health Care
KUBIX vs

Amid the fight against the COVID-19 pandemic, Molarray's PCR machines are used to help detect and id...

Venture round
4 employees
Biotechnology, Health Care

FAQ About KUBIX

Pioneering precision in biotech with comprehensive reagent kits and advanced genetic analysis services
KUBIX was founded in 2004.
KUBIX operates in Biotechnology and Health Care. Its work centres on biotech, precision, reagent kits and genetic analysis.
KUBIX has completed 3 funding rounds, raising a total of $50.00M. The latest funding stage is Corporate Round.
Top alternatives and competitors to KUBIX include ingenetix GmbH, Diatech Pharmacogenetics, Suzhou Molarray Co., Ltd., Dhiti Omics, Advanced Molecular Diagnostics Ltd.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
KUBIX and ingenetix GmbH are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for KUBIX, https://bouncewatch.com/company/kubix-1, updated 26 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes